SCHEMBL7188637

SCHEMBL7188637

O=C(O)c1ccc(OOc2cccc3ccccc23)c(C(=O)O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 1/20 0.53
HSD17B10 Q99714 3/20 0.52
PTPN1 P18031 1/20 0.50
NR4A1 P22736 1/20 0.49
NR4A2 P43354 1/20 0.49
NR4A3 Q92570 1/20 0.49
DAPK1 P53355 1/20 0.48
PIM3 Q86V86 1/20 0.48
KDM4E B2RXH2 5/20 0.46
ALDH1A1 P00352 4/20 0.46
HPGD P15428 3/20 0.46
TDP1 Q9NUW8 1/20 0.45
CDC25B P30305 1/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
PLA2G2D Q9UNK4 1/20 0.43
LMNA P02545 2/20 0.43
MITF O75030 1/20 0.43
POLB P06746 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7191092 0.85 TTR (0.55) MRGPRX4HSD17B10PTPN1NR4A1NR4A2
SCHEMBL7195283 0.84 NR4A1 (0.63) MRGPRX4HSD17B10NR4A1NR4A2NR4A3
SCHEMBL7201515 0.82 MRGPRX4 (0.50) MRGPRX4HSD17B10PTPN1DAPK1PIM3
SCHEMBL7184555 0.80 TTR (0.54) HSD17B10PTPN1NR4A2KDM4EALDH1A1
SCHEMBL27691087 0.78 ALDH1A1 (0.55) MRGPRX4HSD17B10PTPN1KDM4EALDH1A1
SCHEMBL25408413 0.75 ALOX5 (0.56) MRGPRX4HSD17B10NR4A1NR4A2NR4A3
Naphthoic Acid SCHEMBL11300621 0.75 NR4A1 (0.70) MRGPRX4HSD17B10PTPN1NR4A1NR4A2
SCHEMBL788125 0.74 HSD17B10 (0.56) HSD17B10PTPN1NR4A1NR4A2NR4A3
SCHEMBL4289478 0.73 HTR1B (0.59) HSD17B10KDM4EALDH1A1HPGDTDP1
SCHEMBL7190371 0.73 CDC25B (0.73) HSD17B10PTPN1NR4A1NR4A2NR4A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1304924-A2 COMPOSITIONS FOR REPELLING CRAWLING INSECTS Bayer Aktiengesellschaft (DE) 2003-05-02 EP disclosed
US-20020094993-A1 Compositions for repelling crawling insects S.C. JOHNSON & SON, INC. 2002-07-18 US disclosed
WO-2002005646-A2 COMPOSITIONS FOR REPELLING CRAWLING INSECTS S.C. JOHNSON & SON, INC. (US) (US) 2002-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020094993-A1 Compositions for repelling crawling insects ACHE, DDT, GAP43 MRGPRX4 2364/4885HSD17B10 1952/4885PTPN1 2904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.